Revenue
$14.0B
▲ 7.2% YoY
Net Income
$876.5M
▲ 17.5% YoY
EPS
$10.46
▲ 18.3% YoY
Cash
$532.3M
▼ 65.0% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Kyle Kathryn W EVP, Chief Legal Officer | Sell | Jun 8, 2026 | 762 | $263.89 | $201K | Form 4 ↗ |
Schechter Adam H President & CEO | Sell | May 11, 2026 | 5.9K | $254.50 | $1.50M | Form 4 ↗ |
Wilkinson Peter J SVP, Chief Accounting Officer | Sell | Mar 27, 2026 | 1.6K | $267.05 | $436K | Form 4 ↗ |
Meltzer Jonathan C EVP, Operations | Sell | Mar 27, 2026 | 839 | $267.05 | $224K | Form 4 ↗ |
Schechter Adam H President & CEO | Grant | Mar 26, 2026 | 58.5K | $0.00 | $0 | Form 4 ↗ |
Schechter Adam H President & CEO | Sell tax | Mar 26, 2026 | 26.1K | $268.38 | $7.01M | Form 4 ↗ |
GRAHAM ANITA Z EVP, CHRO | Grant | Mar 26, 2026 | 6.6K | $0.00 | $0 | Form 4 ↗ |
GRAHAM ANITA Z EVP, CHRO | Sell tax | Mar 26, 2026 | 2.9K | $268.38 | $773K | Form 4 ↗ |
Schroeder Mark S EVP, Pres Diagnostics & COO | Grant | Mar 26, 2026 | 9.3K | $0.00 | $0 | Form 4 ↗ |
Schroeder Mark S EVP, Pres Diagnostics & COO | Sell tax | Mar 26, 2026 | 4.6K | $268.38 | $1.23M | Form 4 ↗ |
Schroeder Mark S EVP, Pres Diagnostics & COO | Grant | Mar 26, 2026 | 3.0K | $0.00 | $0 | Form 4 ↗ |
Schroeder Mark S EVP, Pres Diagnostics & COO | Sell tax | Mar 26, 2026 | 1.5K | $268.38 | $394K | Form 4 ↗ |
Caveney Brian J EVP, Pres of ED, CMO & CSO | Grant | Mar 26, 2026 | 9.3K | $0.00 | $0 | Form 4 ↗ |
Caveney Brian J EVP, Pres of ED, CMO & CSO | Sell tax | Mar 26, 2026 | 4.0K | $268.38 | $1.08M | Form 4 ↗ |
Caveney Brian J EVP, Pres of ED, CMO & CSO | Grant | Mar 26, 2026 | 2.0K | $0.00 | $0 | Form 4 ↗ |
Caveney Brian J EVP, Pres of ED, CMO & CSO | Sell tax | Mar 26, 2026 | 863 | $268.38 | $232K | Form 4 ↗ |
Wilkinson Peter J SVP, Chief Accounting Officer | Grant | Mar 26, 2026 | 2.4K | $0.00 | $0 | Form 4 ↗ |
Wilkinson Peter J SVP, Chief Accounting Officer | Sell tax | Mar 26, 2026 | 755 | $268.38 | $203K | Form 4 ↗ |
Vaughn Bryan T EVP, Diagnostics | Grant | Mar 26, 2026 | 1.6K | $0.00 | $0 | Form 4 ↗ |
Vaughn Bryan T EVP, Diagnostics | Sell tax | Mar 26, 2026 | 451 | $268.38 | $121K | Form 4 ↗ |
van der Vaart Sandra D EVP, Corporate Affairs | Grant | Mar 26, 2026 | 6.4K | $0.00 | $0 | Form 4 ↗ |
van der Vaart Sandra D EVP, Corporate Affairs | Sell tax | Mar 26, 2026 | 2.7K | $268.38 | $731K | Form 4 ↗ |
Summy Amy B. EVP, Chief Marketing Officer | Grant | Mar 26, 2026 | 4.0K | $0.00 | $0 | Form 4 ↗ |
Summy Amy B. EVP, Chief Marketing Officer | Sell tax | Mar 26, 2026 | 1.8K | $268.38 | $493K | Form 4 ↗ |
Oyegunwa Akinbolade EVP, CIO & CTO | Grant | Mar 26, 2026 | 1.3K | $0.00 | $0 | Form 4 ↗ |
Oyegunwa Akinbolade EVP, CIO & CTO | Sell tax | Mar 26, 2026 | 382 | $268.38 | $103K | Form 4 ↗ |
Meltzer Jonathan C EVP, Operations | Grant | Mar 26, 2026 | 2.4K | $0.00 | $0 | Form 4 ↗ |
Meltzer Jonathan C EVP, Operations | Sell tax | Mar 26, 2026 | 711 | $268.38 | $191K | Form 4 ↗ |